Company Filing History:
Years Active: 2024
Title: Innovations by Tony Moore in Electroporation Technology
Introduction
Tony Moore is an accomplished inventor based in Ballincollig, Ireland. He has made significant contributions to the field of medical technology, particularly in the area of electroporation. With a total of 2 patents to his name, Moore's work focuses on enhancing the efficacy of therapeutic treatments.
Latest Patents
One of Tony Moore's latest patents is an electroporation apparatus and method. This innovative device features electroporation probe terminals that link with electrodes. The apparatus injects a foam at the treatment site to displace blood rather than mixing with it. This process increases the contact time of a higher concentration of active agent with the tissue, resulting in greater efficacy. By utilizing foam solutions, a lower concentration of the agent can achieve the same therapeutic effect as its liquid counterpart. This approach reduces the prevalence of side effects associated with higher concentrations. Furthermore, the foam solution enables more efficient cell electroporation, especially when bipolar pulses are employed. This efficiency mitigates the increase in tissue conductivity typically observed with liquid solutions. Ultimately, a more effective cell permeabilization leads to improved results in electroporation treatments.
Career Highlights
Tony Moore is currently associated with Mirai Medical Limited, where he continues to develop innovative medical technologies. His work has positioned him as a key figure in the advancement of electroporation techniques.
Collaborations
Throughout his career, Tony has collaborated with notable colleagues, including Declan Soden and Colin Forde. These partnerships have contributed to the success of his projects and innovations.
Conclusion
Tony Moore's contributions to electroporation technology demonstrate his commitment to improving therapeutic methods in medicine. His innovative approaches have the potential to enhance treatment efficacy while minimizing side effects.